Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for PTSD in Veterans with Stroke
NCT04885257Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate hydrochloride extended-release chewable tablet in post-traumatic stress disorder (PTSD), ischemic stroke, sponsored by VA Office of Research & Development. Started Jan 2022; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
post-traumatic stress disorder (PTSD)ischemic stroke
Beyond the preview
Go deeper on NCT04885257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885257.